Tertiary Amine N-Oxide Lipids for Liposomal Tissue Penetration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional liposomal drug-delivery systems face challenges with insufficient accumulation and poor permeability in target tissues, limiting their therapeutic efficacy.
Innovation Solution
Development of amphiphilic lipids containing a tertiary amine N-oxide group to replace phospholipids, which enhance drug accumulation and penetration in target tissues through active transcellular transport, prolonging blood circulation time and increasing intratumoral penetration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional phospholipid-based liposomal formulations are used, then the liposomes provide excellent biocompatibility and no toxicity, but they exhibit insufficient accumulation and poor permeability in target tissues
Solution Approach 1:
The patent modifies the chemical structure of phospholipids by introducing a tertiary amine N-oxide group at the sn-2 position, changing the physicochemical parameters of the lipid molecule. This structural parameter change enables the liposome to interact with cell membrane phospholipids through transcytosis, thereby improving drug accumulation in target tissues while maintaining biocompatibility
Solution Approach 2:
The invention creates a composite lipid structure combining the hydrophilic head group with a tertiary amine N-oxide functional group and hydrophobic fatty acid chains. This composite material design allows the liposome to possess both the biocompatibility of traditional phospholipids and the active transcellular transport capability of the N-oxide group
2Stability of the object's composition
If traditional phospholipid-based liposomal formulations are used, then the liposomes provide stable structure, but they exhibit poor permeability and limited therapeutic efficacy
Solution Approach 1:
The patent introduces a tertiary amine N-oxide group at the sn-2 position of phospholipids, changing the chemical reactivity and interaction parameters of the liposome surface. This parameter modification enables active transcellular transport through transcytosis, significantly improving drug penetration while maintaining structural stability
Solution Approach 2:
The tertiary amine N-oxide group acts as an intermediary that facilitates interaction between the liposome and cell membrane phospholipids. This intermediary functional group enables the liposome to be recognized and transported by cellular transcytosis mechanisms, thereby improving penetration without compromising structural integrity
3Quantity of substance
If amphiphilic lipids with tertiary amine N-oxide group are used to replace phospholipids, then drug accumulation and penetration in target tissues is significantly improved, but the complexity of lipid synthesis increases
Solution Approach 1:
The synthesis is divided into two independent stages: first synthesizing the tertiary amine N-oxide-containing fatty acid, then coupling it with the phospholipid head group and hydrophilic moiety. This segmentation of the synthesis process simplifies the overall complexity by breaking down the complex molecular construction into manageable steps
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The amphiphilic lipids significantly improve drug delivery by enhancing accumulation and penetration in target tissues, leading to improved therapeutic effects and reduced drug destruction by lysosomes.
Implementation Method 1
these materials demonstrate strong affinity for phospholipids on cell membranes, are easily adsorbed on cell surfaces and thus endocytosed
Implementation Method 2
Liposomes are phospholipid bilayer vesicles produced by encapsulating a hydrophilic nucleus with one or more concentric phospholipid bilayers
Data Source
AI summary
An amphiphilic lipid including a tertiary amine N-oxide group, a liposomal drug-delivery system, and a use of the amphiphilic lipid are provided. The amphiphilic lipid is a compound shown in a formula I, where R and R′ each are independently selected from C1-C4 alkyl and X is a hydrophobic unit. The amphiphilic lipid can be used alone or together with the traditional phospholipid to prepare a liposomal drug-delivery system. The liposomal drug-delivery system can significantly prolong the blood circulation time of a drug and increase the accumulation and penetration of a drug in target tissues, resulting in a significantly-improved therapeutic effect.